1-2 of 2
Jason Gotlib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B6: Identification of novel mutations in the inhibitory adaptor protein LNK in patients with JAK2 V617F-negative and -positive chronic myeloproliferative neoplasms

Stephen T. Oh, Jacob M. Zahn, Erin F. Simonds, John Bell, Georges Natsoulis, Jason Buenstro, Carol Jones, Matthew B. Hale, Yury Goltsev, Kenneth D. Gibbs, Jr., Jason D. Merker, James L. Zehnder, Ronald W. Davis, Garry P. Nolan, Hanlee P. Ji, Jason Gotlib
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): B6.
https://doi.org/10.1158/1078-0432.TCMUSA10-B6
Published: 02 February 2016
View article titled, Abstract B6: Identification of novel mutations in the inhibitory adaptor protein LNK in patients with JAK2 V617F-negative and -positive chronic myeloproliferative neoplasms
Journal Articles

The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I

Julia E. Maxson, Samuel B. Luty, Jason D. MacManiman, Jason C. Paik, Jason Gotlib, Peter Greenberg, Swaleh Bahamadi, Samantha L. Savage, Melissa L. Abel, Christopher A. Eide, Marc M. Loriaux, Emily A. Stevens, Jeffrey W. Tyner
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 757–764.
https://doi.org/10.1158/1078-0432.CCR-14-3100
Published: 31 January 2016
View article titled, The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I
Open the PDF for The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I in another window
Includes: Supplementary data